Pictet North America Advisors Sa Edwards Lifesciences Corp Transaction History

Pictet North America Advisors Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $99,631 - $153,981	-1,901 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $16,282 - $21,777	-340 Reduced 15.17%	1,901 $364,000
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $13,710 - $17,409	-300 Reduced 11.81%	2,241 $390,000
Q1 2018 May 08, 2018	BUY	$37.19 - $47.45 $94,499 - $120,570	2,541 New	2,541 $355,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet North America Advisors Sa with notifications on news.